Pfizer CentreOne™

Jun 6, 2017

  Pfizer CentreOne™ is a global contract manufacturer that focuses on API synthesis, sterile injectables fill-finish and highly potent solids. For 40+ years, we’ve manufactured complex compounds for our biopharmaceutical partners. Our dedicated team of contract manufacturing experts guide your drug safely from development through commercialization, backed by the quality and resources of Pfizer. Our core capabilities include small-molecule steroid and hormone intermediates and APIs; custom small-molecule API synthesis; sterile injectables fill-finish, where we are known for our experience with complex biologics and lyophilization; and highly potent solid oral dose. Pfizer CentreOne is the union of CMOs Pfizer CentreSource and ...

Read More

WORLDWIDE CLINICAL TRIALS EXPERT TO PRESENT ON PATIENT ENGAGEMENT AT DIA 2017

Jun 6, 2017

Barbara Zupancic, MBA, MSc, to discuss best practices for developing and implementing a patient-centered approach to effectively engage subjects in varying stages of Alzheimer’s Disease. MORRISVILLE, NC, JUNE 1, 2017 – Barbara Zupancic, MBA, MSc, Director, Global Patient Recruitment and Retention at Worldwide Clinical Trials (www.worldwide.com), will present at one of the life sciences industry’s key events – the annual meeting of the DIA (Drug Information Association), being held June 18-21, 2017 in Chicago, Illinois. With patient engagement being a hot topic across the industry with potential touchpoints throughout the life cycle of a product or portfolio, Zupancic will speak ...

Read More

Successful AAALAC accreditation for Envigo facilities in Hyderabad, Indi

Jun 2, 2017

Princeton, NJ, USA June 1, 2017:Envigo has announced that its Research Models and Services (RMS) facility in Hyderabad, India has been granted full accreditation by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International Council. In a letter to Envigo, AAALAC notified the company that it had met all the conditions required for full accreditation and commended the high quality facility and expertise of its people. This is the first accreditation of Envigo sites in 2017 and the sixth in total since the launch of the new company in 2015. The award demonstrates ongoing progress towards Envigo’s ...

Read More

West to Present on Biologics Trends at InnoPack Pharma Confex

May 31, 2017

Presentation caps week-long series of educational seminars throughout India sharing scientific insights and best practices in drug containment and delivery for injectable biologics Exton, PA — May 30, 2017 (Booth #B-3) — West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will deliver a presentation on best practices for improving patient outcomes through integrated containment and delivery systems on June 1, 2017 at the 6th Annual InnoPack Pharma Confex in Mumbai, India. West’s presentation at InnoPack will conclude a week-long series of educational seminars and activities in India focused ...

Read More

mProve Health Achieves Record 12-Month Revenue Growth and Adds 25% More Life Science Clients

May 25, 2017

Demonstrating Profitability for the Seventh Consecutive Year, mProve Health Moves Growing Team into New Headquarter Offices   WASHINGTON, DC – May 22, 2017, mProve Health, a leading provider of mobile technologies used by life science organizations to connect and engage patients with global clinical research studies, announces unprecedented 12-month growth and the addition of 25% more new pharmaceutical companies and CROs to its client base. With contracts for research studies at 18 of the top 20 pharmaceutical companies and more than 15,000 clinical research sites in over 60 countries engaged to enroll patients on mProve’s applications, the company is expanding. ...

Read More